The mean values for the three conditions (Fig 7F; n = 5), clearly demonstrate that inhibiting MEK1/2-ERK1/2 signaling with U0126 prevents the E2-enhanced mitochondrial CRC or E2-mediated inhibition of mPTP opening. This evidence concerns the gene MAPK3 and colorectal carcinoma.